MaxLinear, Inc.MXLNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P21
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -7.37% |
| 2024 | -16.44% |
| 2023 | -9.09% |
| 2022 | 6.47% |
| 2021 | 54.70% |
| 2020 | 83.11% |
| 2019 | -18.02% |
| 2018 | 7.31% |
| 2017 | 14.31% |
| 2016 | 14.45% |